Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Systems approach to characterize the metabolism of liver cancer stem cells expressing CD133
Wonhee Hur, Jae Yong Ryu, Hyun Uk Kim, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

Current status and applications of genome-scale metabolic models
Changdai Gu, Gi Bae Kim, Won Jun Kim, et al.
Genome biology (2019) Vol. 20, Iss. 1
Open Access | Times Cited: 640
RAVEN 2.0: A versatile toolbox for metabolic network reconstruction and a case study on Streptomyces coelicolor
Hao Wang, Simonas Marcišauskas, Benjamín J. Sánchez, et al.
PLoS Computational Biology (2018) Vol. 14, Iss. 10, pp. e1006541-e1006541
Open Access | Times Cited: 314
Metabolic rearrangements in primary liver cancers: cause and consequences
Letizia Satriano, Monika Lewińska, Pedro M. Rodrigues, et al.
Nature Reviews Gastroenterology & Hepatology (2019) Vol. 16, Iss. 12, pp. 748-766
Closed Access | Times Cited: 197
Metabolic reprogramming and its clinical implication for liver cancer
Flora Yang, Leena Hilakivi‐Clarke, Aurpita Shaha, et al.
Hepatology (2023) Vol. 78, Iss. 5, pp. 1602-1624
Open Access | Times Cited: 61
Metabolic Adaptations in Cancer Stem Cells
Umesh Prasad Yadav, Tashvinder Singh, Pramit Kumar, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 124
Targeted Anti-Mitochondrial Therapy: The Future of Oncology
Farzad Taghizadeh‐Hesary, Hassan Akbari, Moslem Bahadori, et al.
Genes (2022) Vol. 13, Iss. 10, pp. 1728-1728
Open Access | Times Cited: 35
Mechanism of cancer stemness maintenance in human liver cancer
Ning Liang, Tao Yang, Qian Huang, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 4
Open Access | Times Cited: 32
Reconstruction of context-specific genome-scale metabolic models using multiomics data to study metabolic rewiring
Jae Sung Cho, Changdai Gu, Tae Hee Han, et al.
Current Opinion in Systems Biology (2019) Vol. 15, pp. 1-11
Closed Access | Times Cited: 46
The Metabolic Heterogeneity and Flexibility of Cancer Stem Cells
Atsushi Tanabe, Hiroeki Sahara
Cancers (2020) Vol. 12, Iss. 10, pp. 2780-2780
Open Access | Times Cited: 43
CCND1 silencing suppresses liver cancer stem cell differentiation and overcomes 5-Fluorouracil resistance in hepatocellular carcinoma
Hao Ding, Yijun Wang, Hongying Zhang
Journal of Pharmacological Sciences (2020) Vol. 143, Iss. 3, pp. 219-225
Open Access | Times Cited: 42
Targeting Cancer Stem Cells by Dietary Agents: An Important Therapeutic Strategy against Human Malignancies
Mahshid Deldar Abad Paskeh, Shafagh Asadi, Amirhossein Zabolian, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 11669-11669
Open Access | Times Cited: 34
Mitochondrial metabolic reprogramming: An important player in liver cancer progression
Tianqiang Jin, Chao Wang, Yu Tian, et al.
Cancer Letters (2019) Vol. 470, pp. 197-203
Closed Access | Times Cited: 35
RAVEN 2.0: a versatile toolbox for metabolic network reconstruction and a case study on Streptomyces coelicolor
Hao Wang, Simonas Marcišauskas, Benjamín J. Sánchez, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2018)
Open Access | Times Cited: 33
Experimental models to unravel the molecular pathogenesis, cell of origin and stem cell properties of cholangiocarcinoma
Silvestre Vicent, Ruby Lieshout, Anna Saborowski, et al.
Liver International (2019) Vol. 39, Iss. S1, pp. 79-97
Open Access | Times Cited: 32
Roles of mitochondria in liver cancer stem cells
Ching-Wen Chang, Jeng‐Fan Lo, Xin Wei Wang
Differentiation (2019) Vol. 107, pp. 35-41
Open Access | Times Cited: 30
The Heterogeneity of Liver Cancer Metabolism
Javier Iván Saravia Salazar, Anne Le
Advances in experimental medicine and biology (2021), pp. 127-136
Open Access | Times Cited: 25
Advances in Liver Cancer Stem Cell Isolation and their Characterization
Lu Liu, Jürgen Borlak
Stem Cell Reviews and Reports (2021) Vol. 17, Iss. 4, pp. 1215-1238
Closed Access | Times Cited: 23
Constraint-Based Reconstruction and Analyses of Metabolic Models: Open-Source Python Tools and Applications to Cancer
Raymond T. Ng, J. Lee, Priyanka Baloni, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 18
Can CD133 Be Regarded as a Prognostic Biomarker in Oncology: Pros and Cons
A. M. Gisina, Yan Kim, K. N. Yarygin, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 24, pp. 17398-17398
Open Access | Times Cited: 10
Multidimensional analysis of tumor stem cells: from biological properties, metabolic adaptations to immune escape mechanisms
Han Han, Ting He, Yingfan Wu, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 3
Systems metabolic engineering as an enabling technology in accomplishing sustainable development goals
Dongsoo Yang, Jae Sung Cho, Kyeong Rok Choi, et al.
Microbial Biotechnology (2017) Vol. 10, Iss. 5, pp. 1254-1258
Open Access | Times Cited: 30
Targeting Liver Cancer Stem Cells: An Alternative Therapeutic Approach for Liver Cancer
Hwa‐Yong Lee, In‐Sun Hong
Cancers (2020) Vol. 12, Iss. 10, pp. 2746-2746
Open Access | Times Cited: 21
The oncometabolite d‑2‑hydroxyglutarate induces angiogenic activity through the vascular endothelial growth factor receptor 2 signaling pathway
Jiyoon Seok, Soo‐Hyun Yoon, Sun‐Hee Lee, et al.
International Journal of Oncology (2018)
Open Access | Times Cited: 22
Genome Scale Modeling to Study the Metabolic Competition between Cells in the Tumor Microenvironment
Itziar Frades, Carles Foguet, Marta Cascante, et al.
Cancers (2021) Vol. 13, Iss. 18, pp. 4609-4609
Open Access | Times Cited: 16
Targeted Anti-mitochondrial Therapy: The Future of Oncology
Farzad Taghizadeh‐Hesary, Babak Behnam, Hassan Akbari, et al.
(2022)
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top